Flublok

Flublok

influenza vaccine

Manufacturer:

Sanofi

Distributor:

Zuellig
Concise Prescribing Info
Contents
Quadrivalent influenza vaccine (recombinant, prepared in cell culture, contains influenza virus haemagglutinin proteins)
Indications/Uses
Active immunization for the prevention of influenza disease in adults.
Dosage/Direction for Use
Contraindications
Hypersensitivity to quadrivalent flu vaccine or to any trace residuals eg, octylphenol ethoxylate.
Special Precautions
Do not inj intravascularly. Do not mix w/ other vaccines in the same syringe. Caution in case of an anaphylactic event following administration. Postpone vaccination in patients w/ acute febrile illness until fever is resolved. Ab response in patients w/ endogenous or iatrogenic immunosuppression may be insufficient to prevent flu. Administer w/ caution to individuals w/ thrombocytopaenia or bleeding disorder. Syncope can occur as psychogenic response to needle inj. May not protect all vaccinees. Assess risks & benefits before administering to a pregnant or breast-feeding woman. Safety & efficacy have not yet been established in individuals <18 yr.
Adverse Reactions
Headache, fatigue; myalgia, arthralgia; local tenderness & pain. Nausea; local firmness/swelling & redness, fever (≥38°C), shivering/chills.
Drug Interactions
Always administer at different inj sites if to be given at the same time as another injectable vaccine.
MIMS Class
Vaccines, Antisera & Immunologicals
ATC Classification
J07BB02 - influenza, inactivated, split virus or surface antigen ; Belongs to the class of influenza viral vaccines.
Presentation/Packing
Form
Flublok vaccine soln for inj 0.5 mL
Packing/Price
10 × 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in